Dallan Murray serves as the Executive Vice President and Chief Customer Officer at Sarepta Therapeutics, Inc., a role in which he leverages his extensive experience in the biopharmaceutical industry to enhance patient access and customer engagement. Prior to joining Sarepta, Murray held various leadership positions that have shaped his career trajectory. He was the Senior Vice President and Chief Commercial Officer at BioMarin Pharmaceutical Inc., where he played a pivotal role in the global launch and commercialization of several innovative therapies. His strategic vision and leadership were instrumental in driving commercial success and expanding market presence. Before his tenure at BioMarin, Murray spent over a decade at Genentech, Inc., where he progressed through several roles of increasing responsibility. At Genentech, he was involved in the successful launch and management of blockbuster oncology and immunology products. His deep understanding of market dynamics and patient needs, combined with his ability to build and lead high-performing teams, have been key to his achievements. At Sarepta, Murray is responsible for overseeing the company's customer-facing functions, including market access, patient services, and commercial operations. His role is crucial in ensuring that Sarepta's groundbreaking therapies reach the patients who need them most, thereby fulfilling the company's mission to improve the lives of those affected by rare diseases.